Cyanide antidotes for mass casualties: Water-soluble salts of the dithiane (sulfanegen) from 3-mercaptopyruvate for intramuscular administration

Journal of Medicinal Chemistry

Volumn 56, Issue 3, 2013, Pages 1346-1349

  Patterson, Steven E ^a   Monteil, Alexandre R ^a   Cohen, Jonathan F ^a   Crankshaw, Daune L ^a,b   Vince, Robert ^a   Nagasawa, Herbert T ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 MERCAPTOPYRUVIC ACID; ANTIDOTE; CYANIDE; SULFANEGEN TRIETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; MALE; MASS DISASTER; NONHUMAN;

ANTIDOTES; CYANIDES; CYSTEINE; HUMANS; INJECTIONS, INTRAMUSCULAR; MASS CASUALTY INCIDENTS; POISONING; QUINOLIZINES; SALTS; SULFUR COMPOUNDS;

EID: 84873905529     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm301633x     Document Type: Article

References (17)

1. Nagahara, N.; Ito, T.; Kitamura, H.; Nishino, T. Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase in the rat: confocal laser fluorescence and immunoelectron microscopic studies combined with biochemical analysis Histochem. Cell Biol. 1998, 110, 243-250
2. Nagahara, N.; Ito, T.; Minami, M. Mercaptopyruvate sulfurtransferase as a defense against cyanide toxication: molecular properties and mode of detoxification Histol. Histopathol. 1999, 14, 1277-1286
3. Nagahara, N.; Sawada, N. The mercaptopyruvate pathway in cysteine catabolism: a physiologic role and related disease of the multifunctional 3-mercaptopyruvate sulfurtransferase Curr. Med. Chem. 2006, 13, 1219-1230
4. Tanabe, S. Development of assay methods for endogenous inorganic sulfur compounds and sulfurtransferases and evaluation of the physiological functions of bound sulfur Yakugaku Zasshi 2008, 128, 881-900
5. Nagahara, N.; Li, Q.; Sawada, N. Do antidotes for acute cyanide poisoning act on mercaptopyruvate sulfurtransferase to facilitate detoxification? Curr. Drug Targets: Immune Endocr. Metab. Disord. 2003, 3, 198-204
6. Testa, B.; Mayer, J. M. Hydrolysis and Prodrug Metabolism. In Chemistry, Biochemistry and Enzymology; VHCA/Wiley-VCH: Zurich, 2003; p 780.
7. Nagasawa, H. T.; Goon, D. J.; Crankshaw, D. L.; Vince, R.; Patterson, S. E. Novel, orally effective cyanide antidotes J. Med. Chem. 2007, 50, 6462-6464
8. Belani, K. G.; Singh, H.; Beebe, D. S.; George, P.; Patterson, S. E.; Nagasawa, H. T.; Vince, R. Cyanide toxicity in juvenile pigs and its reversal by a new prodrug, sulfanegen sodium Anesth. Analg. (Hagerstown, MD, U. S.) 2012, 114, 956-961
9. McNabb, J. W. A Practical Guide to Joint and Soft Tissue Injection and Aspiration: An Illustrated Text for Primary Care Providers, 2nd ed.; Wolters Kluwer Health/Lippencott Williams & Wilkins: Philadelphia, 2010; p 208.
10. Crankshaw, D. L.; Goon, D. J.; Briggs, J. E.; DeLong, D.; Kuskowski, M.; Patterson, S. E.; Nagasawa, H. T. A novel paradigm for assessing efficacies of potential antidotes against neurotoxins in mice Toxicol. Lett. 2007, 175, 111-117
11. Meister, A.; Fraser, P. E.; Tice, S. V. Enzymatic desulfuration of beta-mercaptopyruvate to pyruvate J. Biol. Chem. 1954, 206, 561-575
12. Glomme, A.; März, J.; Jessman, J. B. Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities J. Pharm. Sci. 2005, 94, 1-16
13. Knaak, J. B.; Leung, H. W.; Stott, W. T.; Busch, J.; Bilsky, J. Toxicology of mono-, di-, and triethanolamine Rev. Environ. Contam. Toxicol. 1997, 149, 1-86
14. Heisey, H. O. Infrared Absorption Ratio Method for Determination of Triethanolamine Salicylate in Ointment J. Pharm. Sci. 1964, 53, 1553-1554
15. Maitre, M. M.; Longhi, M. R.; Granero, G. G. Ternary complexes of flurbiprofen with HP-beta-CD and ethanolamines characterization and transdermal delivery Drug Dev. Ind. Pharm. 2007, 33, 311-326
16. Bignami, G. S.; Wagner, F.; Grothaus, P. G.; Rustagi, P.; Davis, D. E.; Kraft, A. S. Biological activity of 26-succinylbryostatin 1 Biochim. Biophys. Acta 1996, 1312, 197-206
17. Deutsch, H. M.; Glinski, J. A.; Hernandez, M.; Haugwitz, R. D.; Narayanan, V. L.; Suffness, M.; Zalkow, L. H. Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity J. Med. Chem. 1989, 32, 788-792